Basic Information
Basic information for NR2F1-AS1-219-42aa
Peptide Name NR2F1-AS1-219-42aa
Genome Position chr5:93409367-93409446,93432415-93432460[-]
Species Human
Peptide Sequence MVSPGLWNILYFNDHDTLPLGLGQIATEYLLQITLHVFSLER
Peptide Length 42
Unique No (NR2F1-AS1-210-42aa,NR2F1-AS1-215-42aa,NR2F1-AS1-216-42aa,NR2F1-AS1-245-42aa,NR2F1-AS1-248-42aa,NR2F1-AS1-249-42aa,NR2F1-AS1-256-42aa,NR2F1-AS1-258-42aa,NR2F1-AS1-264-42aa,NR2F1-AS1-266-42aa,NR2F1-AS1-268-42aa)
Grand Average of Hydropathicity 0.3548
Relative Molecular Mass 5568.27
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000653325;NR2F1-AS1-219
Transcript Length 3370
Coding Ability 0.3662
DNA Sequence Corresponding to Peptide ATGGTGTCCCCTGGTCTTTGGAACATTCTGTATTTTAATGATCATGATACACTGCCTCTAGGACTGGGACAGATAGCCACTGAGTACCTGCTTCAAATCACCCTGCACGTTTTCTCTTTGGAAAGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :